Functional Genomics and Proteomics - Applications, Molecular Diagnostics & Personalized Medicine

Poster Programme

Posters are presented during the poster party on Thursday, 31 January 2013, 18:00 - 20:30 hrs and during lunch and coffee breaks. The authors are expected to be present during the poster party.

The three best posters will be selected and the poster prizes, each endowed with EUR 300, will be awarded on Friday, 1 February 2013 at 12:25 hrs. All authors are expected to be present.

P01 Point-of-care diagnostics: first steps towards a new platform for drug screening
        S. Schumacher, Fraunhofer Instiute for Biomedical Engineering, Potsdam

P02 3D-hydrogel matrix for improved bioanalytical applications
         A. Beyer, S. Pollok, K. Weber, J. Popp, Institute of Photonic Technology, Jena

P03 Rank aggregation for candidate gene selection
        A. Burkovski, L. Lausser, H.A. Kestler, Ulm University

P04 A fast solution to NGS library preparation with low nanogram DNA input
        P. Liu, G.J.S. Lohman, E. Cantor, B.W. Langhorst, E. Yigit, New England Biolabs Inc.,
        Ipswich, MA/USA; B. Textor, New England Biolabs GmbH, Frankfurt am Main; L.M. Apone,
        D.B. Munafo, C. Sumner, F.J. Stewart, T.C. Evans Jr., E.T. Dimalanta, T.B. Davis, New
        England Biolabs Inc., Ipswich, MA/USA

P05 Development of living cell microarrays as analytical test systems for biomarker
        detections

        R. Bongartz, F. Stahl, T. Scheper, Gottfried Wilhelm Leibniz University Hanover

P06 A mathematical model of Wnt response: switch behavior as a result of asymmetric
        mutual concentration dependent inhibition

        E. Sträng, M. Kühl, H.A. Kestler, Ulm University

P07 The critical noise level for learning Boolean functions
        M. Maucher, H.A. Kestler, Ulm University

P08 Development of a device platform for predictive and prognostic point-of-care testing
        using the example of pathogen identification

        F. Scherag, University of Freiburg; R. Götzen, microTEC Gesellschaft für Mikrotechnologie
        mbH, Duisburg; G. Sulz, Fraunhofer Institute for Physical Measurement Technique (IPM),
        Freiburg; M. Schmidt, Micropelt GmbH, Freiburg; M. Panning, University of Freiburg; H. Attig,
        Qiagen GmbH, Hilden; T. Brandstetter, J. Rühe, University of Freiburg

P10 Simultaneous amplification and detection of multiple miRNAs and mRNAs
        
A. Mader, U. Riehle, T. Brandstetter, J. Rühe, University of Freiburg

 P11 A polymer-based protein microarray technology for multiparametric cytokine analysis
        
A. Evers, T. Brandstetter, University of Freiburg; T. Neß, T. Reinhard, University Eye Hospital
         of Freiburg; J. Rühe, University of Freiburg

 P12 Identification of autoantibody biomarkers for colon cancer screening using protein
         microarrays

         J. Luna Coronell, K. Sergelen, R. Kulovics, AIT Austrian Institute of Technology GmbH,
         Vienna/A; P. Hofer, A. Gsur, Medical University Vienna/A; J. Hofbauer, F. Längle,
         Landesklinikum Wiener Neustadt/A; A. Weinhäusel, AIT Austrian Institute of Technology
         GmbH, Vienna/A

P13 Chip-based molecular diagnostic for detection of a cancer related single nucleotide
        polymorphism

        C. Steinbach, C. Steinbrücker, K. Weber, J. Popp, Institute of Photonic Technology (IPHT),
        Jena

 P14 High throughput profiling of the human immune repertoire using a high density peptide
         array platform

         K. Stengele, J. Bühler, Nimblegen Systems GmbH, Waldkraiburg

 P15 Fraunhofer ivD-platform: assessment of cardiac risk using a creditcard-sized system
         for patient-near testing

         D. Sartorius, E. Rümpel, D. Michel, S. Schumacher, E. Ehrentreich-Förster, Fraunhofer
         Institute for Biochemical Engineering IBMT, Potsdam

 P16 Cell free bioengineering of human growth factors followed by their identification via
          intracellular transformation by nPS in vitro

          N. Klehr, L. Bauer, H. Focke, B. Brüderl, J. Setter, Dr. Klehr Institut für Immunologie und
          Zellbiologie, Munich

 P17 Antibody microarray-based proteomics of pancreatic stellate cells under various
         pro-inflammatory stimuli

         A. Marzoq, J.D. Hoheisel, M.S.S. Alhamdani, German Cancer Research Center, Heidelberg

 P18 Proteomics of blood cellular components by means of antibody microarrays
        
R. Uhler, A. Marzoq, J.D. Hoheisel, M.S.S. Alhamdani, German Cancer Research Center,
         Heidelberg

P19 Sensitive and simultaneous profiling of hundreds of transcripts from a single cell on
        the nCounter platform

        M. Krouse, NanoString Technologies, Seattle, WA/USA; J. White, NanoString Technologies,
        Liverpool/UK; B. Burditt, L. Dennis, R. Boykin, G. Geiss, P. Webster, NanoString
        Technologies, Seattle, WA/USA

P20 Finding a minimal gene set for cancer
        M.B. Grieb, J.M. Kraus, Ulm University; M. Buchholz, Marburg University Hospital;
        K.L. Rudolph, Fritz-Lipmann-Institut e.V., Jena; H.A. Kestler, Ulm University

P21 High-content peptide microarrays for the identification of new cancer and autoimmune
        biomarkers as well as antigen and epitope discovery

        T. Felgenhauer, L. Steinbrück, V. Stadler, PEPperPRINT GmbH, Heidelberg; R. Bischoff,
        German Cancer Research Center, Heidelberg

P22 Unraveling the substrate specificity of human acetyltransferases by peptide
        microarrays

        A. Masch, C. Roessler, D. Rauh, University Halle-Wittenberg; M.O. Hottiger, University of
        Zurich/CH; M. Schutkowski, University Halle-Wittenberg

P23 Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine by forced mitotic
        entry - a target discovered by pooled RNAi screening

       J. Fredebohm, M. Boettcher, J. Wolf, J.D. Hoheisel, German Cancer Research Center,
       Heidelberg

P24 New set of potential tumor marker by mRNA and miRNA profiling in human pancreatic
        cancer

        A. Bauer, German Cancer Research Center, Heidelberg; A. Keller, febit biomed GmbH,
        Heidelberg; E. Costello-Goldring, W. Greenhalf, Royal Liverpool University Hospital/UK;
        M. Bier, German Cancer Research Center, Heidelberg; M. Beier, febit biomed GmbH,
        Heidelberg; J. Werner, University Heidelberg; J. Neoptolomeos, Royal Liverpool University
        Hospital/UK; M. Büchler, N. Giese, University Heidelberg; J.D. Hoheisel, German Cancer
        Research Center, Heidelberg

P25 Development of pipelines for high-throughput data analyses, primer and assay design
        R. Kallmeyer, R.V. Pandey, A. Weinhäusel, A. Kriegner, AIT Austrian Institute of Technology
        GmbH, Vienna/A

P26 Stain-free technology as normalization tool in Western blot analysis
        A. Posh, Institute of Radiation Biology, Munich; R. Bogoev, Bio-Rad Laboratories,
       Hercules/USA; S. Tapio, Institute of Radiation Biology, Munich

P27 Genedata Expressionist for omics data management
        T. Zeppenfeld, K. Fink, Genedata AG, Basel/CH

P28 Multiplex immunoassay for catecholamines
        N. Baur, N. Schneiderhan-Marra, NMI Natural and Medical Sciences Institute, Reutlingen;
        E. Booltink, G. Manz, LDN Labor Diagnostika Nord GmbH & Co. KG, Nordhorn; T. Joos, NMI
        Natural and Medical Sciences Institute, Reutlingen; B. Manz, LDN Labor Diagnostika Nord
        GmbH & Co. KG, Nordhorn

P29 Combined analysis of coding, non-coding transcriptomes and methylomes of pancreatic
        ductal adenocarcionmas (PDACs)

        S. Müller, Goethe University Frankfurt am Main; B. Rotter, A. Plötner, K. Hoffmeiner, GenXPro
        GmbH, Frankfurt am Main; S. Raulefs, TU München; P. Winter, GenXPro GmbH, Frankfurt
        am Main; G. Kahl, Goethe University Frankfurt am Main

P30 Development of an aptamer-based biosensor for detection of small molecules
       
A. Heilkenbrinker, J.-G. Walter, F. Stahl, T. Scheper, Leibniz University Hanover

P31 Monitoring drug metabolizing enzymes - immuno MRM analysis of the cytochrome P450
        system using TXP antibodies

        F. Weiß, H. Planatscher, NMI Natural and Medical Sciences Institute, Reutlingen; R. Zahedi,
        ISAS, Dortmund; K. Marcus, Medizinisches Proteom-Center, Bochum; T. Joos, O. Poetz,
        NMI Natural and Medical Sciences Institute, Reutlingen

P32 Integrative prioritization of candidate disease genes for personalized systems medicine
       
T. Kacprowski, University Medicine Greifswald; N.T. Doncheva, Max Planck Institute for
        Informatics, Saarbrücken; M. Albrecht, University Medicine Greifswald

P33 Multiplexed antigen arrays for the analysis of the human serological response for HCV
        genotype 4

        A. Filomena, J. Göpfert, T. Joos, N. Schneiderhan-Marra, NMI Natural and Medical Sciences
        Institute, Reutlingen

 

 

 

 

 

 

 

Veranstaltungen
Jetzt Mitglied werden